Eric Blasius Risser - Mar 4, 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: Chief Operating Officer
Signature: /s/ Lynn Cilinski, Attorney-in-Fact
Stock symbol: MGNX
Transactions as of: Mar 4, 2022
Transactions value $: $470
Form type: 4
Date filed: 3/4/2022, 04:45 PM
Previous filing: Feb 24, 2022
Next filing: Oct 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Options Exercise	$470	+500	+1.12%	$0.94^*	45K	Mar 4, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Employee stock option (right to buy)	Options Exercise	$0	-500	-100%	$0.00^*	0	Mar 4, 2022	Common Stock	500	$0.94	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.